CVS Caremark replaces Zepbound with Wegovy on its preferred medication list, requiring patients to change.
CVS Caremark Drops Zepbound, Shifts to Wegovy for Weight Loss Many patients using GLP-1 medications for weight loss are navigating a frustrating shift due to changes in insurance coverage. With CVS Caremark, one of the major pharmacy benefit managers in the U.S., announcing it will discontinue coverage for Zepbound (Tirzepatide) as of July 1, this […]
Mounjaro and Zepbound no longer in shortage
About two years later, federal regulators announced that the shortage of active ingredients in Mounjaro and Zepbound had been resolved. Tirzepatide, the active ingredient in diabetes and obesity drugs Mounjaro and Zepbound, was declared in short supply in December 2022. The cause of the shortage is believed to be increased demand due to increased interest […]
Eli Lilly selling weight-loss drug Zepbound for 50% less
In response to surging demand, Eli Lilly said it has begun selling single-dose vials of its wildly popular weight-loss drug Zepbound, with the small doses priced 50 percent lower than competing drugs. The more affordable vials are sold to patients whose health insurance doesn't reimburse them for the weight-loss drug. The company said it would […]